Tuberculosis Treatment Shortening Trial

NCT00130247 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

394

Enrollment

NIH

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: Ethambutol
DRUG: Isoniazid
DRUG: Pyrazinamide
DRUG: Rifampin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)